Skip to content

Enoxacin

ANTIINFECTIVES FOR SYSTEMIC USE

Also known as: enofloxacin, enofloxacine, enoksetin, enoxacine

OfmFDA approvedATC J01MA04

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Enoxacin is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1991. DrugCentral lists 5 molecular targets, including TARBP2, ATP6V1B2 and gyrA. Recorded indications include Acute gonococcal cervicitis, Acute gonococcal urethritis, Gonorrhea and Gonorrhea of pharynx.

  • Approval status: ofm (first approved 1991 by the FDA).
  • Molecular targets: TARBP2, ATP6V1B2, gyrA and parC|topB (5 listed in DrugCentral).
  • Indications: Acute gonococcal cervicitis, Acute gonococcal urethritis, Gonorrhea, Gonorrhea of pharynx and Gonorrhea of rectum and others.
  • ATC code: J01MA04 (Fluoroquinolones).
  • Molecular formula: C15H17FN4O3; molecular weight 320.32 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (6)

  • Acute gonococcal cervicitis
  • Acute gonococcal urethritis
  • Gonorrhea
  • Gonorrhea of pharynx
  • Gonorrhea of rectum
  • Urinary tract infectious disease

Off-label uses (1)

  • Chancroid

Mechanism & targets

Molecular targets (5)

TargetGeneActionActivity
RISC-loading complex subunit TARBP2TARBP2unknownKd 7.03
V-type proton ATPase subunit B, brain isoformATP6V1B2unknownIC50 5.00
DNA gyrase subunit AgyrAunknown—
Topoisomerase IVparC|topBinhibitor—
DNA gyrasegyrB|gyrAinhibitor—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1991-12-31FDA——

ATC classification

ATC codeTherapeutic hierarchy
J01MA04ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › QUINOLONE ANTIBACTERIALS › Fluoroquinolones

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Enoxacin is on its molecule page.

Molecular formulaC15H17FN4O3
Molecular weight320.32 g/mol
CAS number74011-58-8
InChIKeyIDYZIJYBMGIQMJ-UHFFFAOYSA-N
PubChem CID3229
CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N=C12)N1CCNCC1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Enoxacin used for?

DrugCentral lists the following indications for Enoxacin: Acute gonococcal cervicitis, Acute gonococcal urethritis, Gonorrhea, Gonorrhea of pharynx, Gonorrhea of rectum and Urinary tract infectious disease.

How does Enoxacin work?

Its molecular targets in DrugCentral include TARBP2, ATP6V1B2, gyrA and parC|topB (inhibitor).

When was Enoxacin first approved?

Enoxacin was first approved by the FDA in 1991.

What is the chemical formula of Enoxacin?

Enoxacin has the molecular formula C15H17FN4O3 and a molecular weight of 320.32 g/mol.

Browse: all drugs starting with E · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1991-12-31
AgencyFDA
Targets5
Indications6
FormulaC15H17FN4O3
DrugCentral ID1013
Interactive profile